Am Heart J

1. MARTINS E, Tavares CAM, Favaro L, Monfardini F, et al
   Rationale and Design of a Pragmatic Randomized Clinical Trial Assessing a Smartphone-Based Digital Health Intervention in Hypertension: The ELFIE-HYPERTENSION trial.
   Am Heart J. 2026 Feb 10:107380. doi: 10.1016/j.ahj.2026.107380.
   

   >> Share

   
   

   
   Am J Hypertens

2. LIU H, Lyu T, Wu Y, Zhao H, et al
   Hypertension and New-Onset atrial Fibrillation in Participants with Diabetes Mellitus: A Report from the Population-Based kailuan Study.
   Am J Hypertens. 2026 Feb 15:hpag011. doi: 10.1093.
   

   >> Share

   
   
3. LIWELEYA S, Siame L, Hamooya BM, Chota A, et al
   Reframing Insulin Resistance and Hypertension in type 2 Diabetes: Clinical and Mechanistic-Level Insights from Non-Insulin-Based Biomarkers.
   Am J Hypertens. 2026 Feb 14:hpag010. doi: 10.1093.
   

   >> Share

   
   
4. SWEIGERT J, Gruenewald T, Lachman M, Seeman T, et al
   Dynamical Regulation of Blood Pressure and Cognitive Function.
   Am J Hypertens. 2026;39:231-240.
   

   >> Share

   
   
5. LIN L, Lu B, Wang H, Zhang Y, et al
   Associations of Blood Pressure Fluctuation Patterns With Cognitive Function: The Mediating Role of Cumulative Blood Pressure.
   Am J Hypertens. 2026;39:272-279.
   

   >> Share

   
   
6. BERLOT AA, Berman J, Borad A, Mason TD, et al
   Remote Blood Pressure Monitoring: A Comprehensive Review.
   Am J Hypertens. 2026;39:188-197.
   

   >> Share

   
   

   
   BMJ

7. WISE J
   Apple smartwatch hypertension feature risks false reassurance, warn doctors.
   BMJ. 2026;392:s268.
   

   >> Share

   
   

   
   Circulation

8. JAMBON-BARBARA C, Suissa S, Dell'Aniello S, Hlavaty A, et al
   Second- and Third-Generation BCR-ABL Tyrosine Kinase Inhibitors and the Risk of Pulmonary Arterial Hypertension: A Prevalent New-User Design.
   Circulation. 2026 Feb 12. doi: 10.1161/CIRCULATIONAHA.125.077764.
   

   >> Share

   
   
9. REDDY YNV, Frantz RP, Miranda WR, Asokan AK, et al
   Elevated Pulmonary Artery Wedge Pressure in Group 1 Pulmonary Hypertension.
   Circulation. 2026 Feb 13. doi: 10.1161/CIRCULATIONAHA.125.077606.
   

   >> Share

   
   

   
   Clin Exp Hypertens

10. YALCIN MU, Gurses KM, Tuncez A, Tezcan H, et al
    Association of blood pressure dipping status with Naples Prognostic Score and arterial stiffness in newly diagnosed hypertensive patients.
    Clin Exp Hypertens. 2026;48:2627333.
    

    >> Share

    
    

    
    Eur Heart J

11. CREA F
    Focus on trials: atrial fibrillation, heart failure with reduced ejection fraction, acute coronary syndrome, ischaemic stroke, and renovascular hypertension.
    Eur Heart J. 2026;47:649-654.
    

    >> Share

    
    
12. TADDEI S, Narkiewicz K, Bricout-Hennel S, Petrova P, et al
    Quadruple vs triple therapy for resistant hypertension: the QUADRO trial.
    Eur Heart J. 2026 Feb 11:ehag022. doi: 10.1093.
    

    >> Share

    
    
13. LI XM, Yang L, Yang ZG
    Taussig-Bing heart with pulmonary hypertension in a rare adult survivor: multimodality imaging insights.
    Eur Heart J. 2026 Feb 9:ehag026. doi: 10.1093.
    

    >> Share

    
    

    
    Hypertension

14. LIU M, Liu X, Zhan P, Jin H, et al
    MYDGF Governs Endothelial Homeostasis in Hypertension.
    Hypertension. 2026 Feb 13. doi: 10.1161/HYPERTENSIONAHA.125.25816.
    

    >> Share

    
    
15. LEI J, Wu H, Liu H, Poon LC, et al
    DNA Methylation Markers for Pregnancy Hypertension via Machine Learning Methods.
    Hypertension. 2026 Feb 11. doi: 10.1161/HYPERTENSIONAHA.125.25388.
    

    >> Share

    
    
16. BROWN MJ, Drake WM
    Resistant Hypertension Is Not Essential: It Is Primarily Aldosteronism.
    Hypertension. 2026 Feb 10. doi: 10.1161/HYPERTENSIONAHA.125.26401.
    

    >> Share

    
    

    
    J Am Coll Cardiol

17. KREUTZ R, Brunstrom M
    Beyond the RAAS: The Search for Novel Antihypertensive Therapies: A Needle in the Haystack?
    J Am Coll Cardiol. 2026 Feb 3:S0735-1097(25)10581.
    

    >> Share

    
    
18. SUNG KC, Park K, Kim DH, Lim SW, et al
    Single-Pill Low-Dose Triple Combination Therapy vs Standard-Dose Monotherapy in Patients With Mild-to-Moderate Hypertension.
    J Am Coll Cardiol. 2026 Feb 3:S0735-1097(25)10559.
    

    >> Share

    
    

    
    J Cardiovasc Pharmacol

19. KIM HL, Lee B, Im S
    The comparative effects of S-amlodipine versus racemic amlodipine on long-term cardiovascular outcomes in subjects with hypertension: a nationwide population-based cohort study.
    J Cardiovasc Pharmacol. 2026 Feb 9. doi: 10.1097/FJC.0000000000001793.
    

    >> Share

    
    

    
    J Hum Hypertens

20. SINGH A, Singh MP, Thakur P, Khasbage SU, et al
    Efficacy of pharmacological agents for management of post-partum hypertension: A systematic review and network meta-analysis.
    J Hum Hypertens. 2026 Feb 9. doi: 10.1038/s41371-026-01120.
    

    >> Share

    
    

    
    J Hypertens

21. FLYNN JT, Kruger R, Brady TM, Chanchlani R, et al
    Practical approach to evaluate and manage hypertension in youth: an International Society of Hypertension position paper.
    J Hypertens. 2026 Feb 7. doi: 10.1097/HJH.0000000000004238.
    

    >> Share

    
    
22. ZHOU J, Zeng Z, Huang Y, Guo C, et al
    Association of lean body mass and fat mass with peripheral arterial disease events in hypertensive patients.
    J Hypertens. 2026 Feb 11. doi: 10.1097/HJH.0000000000004261.
    

    >> Share

    
    
23. MIAH B, Marianne Geleijnse JM, Grobbee DE, van der Schouw YT, et al
    Dietary modification of blood pressure-lowering effects of antihypertensive drugs - a scoping review.
    J Hypertens. 2026 Feb 11. doi: 10.1097/HJH.0000000000004247.
    

    >> Share

    
    
24. KOLOSSVARY E, Ferenci T, Jarai Z, Farkas K, et al
    Alternative ankle-brachial assessments show no significant added value in predicting mortality of hypertensive patients.
    J Hypertens. 2026 Jan 30. doi: 10.1097/HJH.0000000000004255.
    

    >> Share

    
    
25. YEO LF, Palmu J, Havulinna AS, Parnanen K, et al
    Prospective association between the gut microbiome and incident hypertension: a 20-year cohort study.
    J Hypertens. 2026 Jan 30. doi: 10.1097/HJH.0000000000004254.
    

    >> Share

    
    

    
    JAMA

26. COHEN JB, Addo DK, Jacobs JA, Greene TH, et al
    Impact of a Smartwatch Hypertension Notification Feature for Population Screening.
    JAMA. 2026 Feb 9. doi: 10.1001/jama.2025.26925.
    

    >> Share

    
    

    
    Lancet

27. AZIZI M, Tuttle KR, Brown JM, Piskorz DL, et al
    New drug therapies for hypertension.
    Lancet. 2026 Feb 10:S0140-6736(25)02064-1. doi: 10.1016/S0140-6736(25)02064.
    

    >> Share

    
    

    
    N Engl J Med

28. FADAKAR PK, Pourvaziri A, Feldman AS, Pier DB, et al
    Case 5-2026: An 18-Year-Old Woman with Headache and Hypertension.
    N Engl J Med. 2026;394:700-709.
    

    >> Share

    
    

    
    PLoS Med

29. LAFFIN LJ, Nissen SE
    Aldosterone synthase inhibitors for hypertension: A breakthrough facing barriers to adoption.
    PLoS Med. 2026;23:e1004900.
    

    >> Share

    
    

    
    PLoS One

30. ABDULAI K, Osman Aleboko S, Anane I, Addae-Mensah I, et al
    Prevalence and determinants of hypertension among people living with HIV in Ghana: A cross-sectional study.
    PLoS One. 2026;21:e0342198.
    

    >> Share

    
    
31. ANKOMANIN T, Konlan KD, Korsah KA
    Health seeking behaviors of nurses diagnosed with hypertension and providing health care in resource-constrained setting in a rural part of Northern Ghana: A qualitative study.
    PLoS One. 2026;21:e0342406.
    

    >> Share

    
    
32. OPATRIL L, Mojica-Pisciotti ML, Panovsky R, Machal J, et al
    Comparison of pulmonary circulation parameters acquired by cardiovascular magnetic resonance with right heart catheterization and transthoracic echocardiography in patients with recent-onset dilated cardiomyopathy.
    PLoS One. 2026;21:e0341438.
    

    >> Share

    
    

    
    Proc Natl Acad Sci U S A

33. LEBENDER LF, Seidinger A, Matthey M, Dyck B, et al
    Beta arrestin 1 is a key regulator of pulmonary vascular tone.
    Proc Natl Acad Sci U S A. 2026;123:e2512602123.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share